Semler Scientific, Inc. offers training, quality assurance, analytics, technical support and EMR integration so that QuantaFlo users can deliver quick and accurate results at home or in a clinical setting.
The QuantaFlo PAD test delivers fast, accurate results in less than 5-minutes at the point-of-care when the opportunity to improve health and lower cost is the greatest. Easy to use and portable, the QuantaFlo software runs on Windows, Android and iOS platforms.
QuantaFlo is routinely used in hospitals, clinics, primary care, internal medicine, specialty practices and home health settings.
Almost 20 million U.S. citizens suffer from Peripheral Arterial Disease.4 It is often undiagnosed as clinical signs and symptoms are not typically present during the early stages of the disease.
QuantaFlo can help detect early atherosclerotic changes in those patients with common risk factors such as age, diabetes, smoking, ethnicity, hypertension and hyperlipidemia.
The use of the QuantaFlo system has been fantastic and user friendly. It has an easy-to-read method of performing the test on a patient along with user error codes that will help the staff make the necessary corrections when needed. Overall, I am happy with the device and we will continue relying on its accuracy to better assist our patients.
Being able to partner and collaborate with Semler since our launch in 2019 has been instrumental in how we are able to add more to in-home healthcare for our members across the country. Working together has built a strong relationship rooted in innovation and adaptation to our fast-paced medical and technology world.
After I implemented QuantaFlo into my office for several patients, I tested patients with multiple comorbidities with astonishing results. Most clinicians wait for 'claudication at rest' before they start to investigate. In reality, many patients were symptomatic after more detailed inquiry. We were able to refer appropriate cases to the vascular surgeon for exceptional outcomes.
I instituted QuantaFlo in our wound center to identify patients for peripheral vascular disease in poorly healing wounds. The ease of performing QuantaFlo by our MAs provides our wound care clinicians additional critical decision-making information to revascularize a select group of patients for optimal healing.
No matter what your question, we’ll try to help. Responses can be expected within a few days.